Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06656754 · ClinicalTrials.gov registry record · Early Phase 1
R01.Aim 2.Study 1: IsoReach
A Early Phase 1 study of Stroke, sponsored by Shirley Ryan AbilityLab.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT06656754: Recruiting Early Phase 1 study of Stroke, sponsored by Shirley Ryan AbilityLab.
NCT06656754 is a Early Phase 1 study of Stroke that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 56 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06656754, a Early Phase 1 study of Stroke, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effects of 3D isometric movement training in healthy participants and impaired participants due to a stroke.
Primary Outcome
Maximum distance between the ideal reaching trajectory and the actual trajectory made in unconstrained and constrained movement conditions
Conditions Studied
Interventions
- OTHER Isometric Reaching
Study Locations (1)
Illinois
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-11-17 |
| Est. Completion | 2029-05-01 |
| Phase | Early Phase 1 |
What NCT06656754 shows while recruiting
NCT06656754 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Isometric Reaching is the first listed.
NCT06656754 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06656754 about?
NCT06656754 is a clinical study titled "R01.Aim 2.Study 1: IsoReach". To determine the effects of 3D isometric movement training in healthy participants and impaired participants due to a stroke.
What is the current status of trial NCT06656754?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 56 participants. The study started on 2024-11-17. Estimated completion is 2029-05-01.
What conditions does trial NCT06656754 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT06656754?
The interventions under investigation include: Isometric Reaching (OTHER).
Who is sponsoring clinical trial NCT06656754?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06656754 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06656754's enrollment target sits among peer trials
56 220th of 454 higher than 231 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Primed Stroke Rehabilitation
RECRUITING · Early Phase 1
-
Effect of Neural Constraints on Movement in Stroke
RECRUITING · Early Phase 1
-
Multisensory Augmentation for Post-stroke Standing Balance
RECRUITING · Early Phase 1
-
Cognition and Motor Learning Post-stroke
RECRUITING · Early Phase 1
-
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
RECRUITING · Early Phase 1
-
Assistance Delivery and Muscle Coordination
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI